Xpert Xpress MVP, GeneXpert Dx System, GeneXpert Infinity System

FDA 510(k) K212213 · Cepheid

Substantially Equivalent

510(k) numberK212213

Submission

Device name
Xpert Xpress MVP, GeneXpert Dx System, GeneXpert Infinity System
Applicant
Cepheid
Sunnyvale, CA, US
Received
July 15, 2021
Decision date
February 9, 2022
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PQA – Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3975
Specialty
Microbiology

A vaginitis and bacterial vaginosis nucleic acid detection system is a qualitative in vitro diagnostic device for the direct detection of nucleic acid sequences from microorganisms associated with vaginitis or bacterial vaginosis. The device is indicated for individuals with signs and symptoms of vaginitis or bacterial vaginosis and aids in the diagnosis of these vaginal infections.

Other 510(k)s with product code PQA

510(k)DeviceApplicantDecision
K260021cobas® BV/CVPQA · Traditional Roche Molecular Systems, Inc.07/16/2026SE
K243725BD Vaginal PanelPQA · Special Becton, Dickinson and Company12/19/2024SE
K243345Aptima BV Assay; Aptima CV/TV AssayPQA · Special Hologic, Inc.11/25/2024SE
K231381Xpert Xpress MVP; GeneXpert Xpress SystemPQA · Dual Track Cepheid10/19/2023SE
K223653BD Vaginal PanelPQA · Traditional Becton, Dickinson and Company03/06/2023SE
K221160Xpert Xpress MVP, GeneXpert Dx System, GeneXpert Infinity SystemPQA · Special Cepheid06/07/2022SE
K201017BD MAX Vaginal Panel, BD MAX System, BD Molecular Swab Collection KitPQA · Traditional Geneohm Sciences Canada, Inc. (Bd Life Sciences)10/18/2021SE
K191957BD MAX Vaginal PanelPQA · Traditional Geneohm Sciences Canada, Inc. (Bd Diagnostics)10/21/2019SE
K190452Aptima BV AssayPQA · Traditional Hologic, Inc.05/23/2019SE
K190472Aptima CV/TV AssayPQA · Traditional Hologic, Inc.05/16/2019SE

More from Hologic, Inc.

510(k)DeviceDecision
K261362Xpert Hemorrhagic FeverQVR · Dual Track 08/07/2026SE
K261867Xpert Carba-RPOC · Special 07/02/2026SE
K253653Xpert Hemorrhagic Fever · Traditional 02/20/2026SE
K251721Xpert GI PanelPCH · Traditional 01/16/2026SE
K250996Xpert Xpress CoV-2/Flu/RSV plusQOF · Special 05/01/2025SE
K250995Xpert Xpress CoV-2/Flu/RSV plusQOF · Special 05/01/2025SE
K243730Xpert C. difficile/EpiOZN · Traditional 02/28/2025SE
K250218Xpert® FII & FVNPR · Special 02/21/2025SE
K242109Xpert® Xpress CoV-2 plus (XPRS-COV2-10)QQX · Dual Track 01/15/2025SE
K242071Xpert Xpress CoV-2/Flu/RSV plusQOF · Dual Track 01/10/2025SE

Questions and answers

When was Xpert Xpress MVP, GeneXpert Dx System, GeneXpert Infinity System cleared by the FDA?

Xpert Xpress MVP, GeneXpert Dx System, GeneXpert Infinity System (K212213) received a 510(k) decision of Substantially Equivalent on February 9, 2022, 209 days after the submission was received.

What is the product code of K212213?

The FDA product code is PQA – Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System, a Class II (moderate risk) device regulated under 21 CFR 866.3975.